Framework for Risk Assessment Flashcards
Risk Assessment Framework
5
- Problem Formulation
- Hazard Identification
- Dose-Response Assessment
- Exposure Assessment
- Risk Characterization
PHEDR
What is the main goal of problem formulation?
to figure out the technical and analytical approach
Subgoals of problem formulation
Goals:
1. Identify issues to be assessed
1. Identify goals, breadth, depth, and focus of risk assessment (like scope & limitations)
1. Establishes who the decision maker, stakeholders, risk assessor are
what, so what, who
Differentiate
Problem Formulation - Outputs
2
Conceptual model
* Taken from literature
* environmental stressors, pathways, sources, populations at risk, potential adverse effects
Analysis plan
* how to locate pollution data
* What chemicals of concern
* How to assess & measure doses, exposures
* what risk metrics to use
* Other technical requirements
Importance of Problem Formulation 3
- Ensure commitment of stakeholders & decision makers
-
Better chance of finding acceptable policy solution
* Stakeholders & DMs should be in process from very beginning — some sort of ownership on the decision - Save time and resources
Explain the main challenge of Problem Formulation
- Need to balance extensive dialogue & practical efficiency
- Can take away time
Hazard Identification - Goal
to understand the extent of harm caused by a specific hazard
Hazard Identification - 4 subgoals
- determine adverse effects related to exposure
- do an RRL - choose from data & evaluate supporting scientific evidence (maganda ba)
- produce a list of potential toxic effects - so people know wtf is going on
- establish causation - describe nature & strength
List
Hazard Identification - Sources of Evidence
4
- Epidemiology
- Toxicology
- In-vitro studies
- In-silico studies
Describe
Epidemiology as a Source of Evidence for Hazard Identification
- observational human studies
- Mostly observational, about correlations
* No controlling of variables/experimenting
Toxicology as a Source of Evidence for Hazard Identification
experimental animal evidence
* More definitive causation
* Arguments surrounding testing on animals
* Concerned w/ symptoms & doses
* we shifted towards this bc it’s unethical to do it on humans
In-vitro studies as a Source of Evidence for Hazard Identification
in-vitro studies – cell-based studies
* Eg. Ivermectin – tested on a petri dish
* Principle of emergent property: cell acting different outside of its system
* Works well for dermal absorption properties – Estee Lauder is leaning more towards in-vitro testing now
Define
Principle of emergent property
cell acting different outside of its system
it gains the property when it works with other components in a system, however the property does not manifest when the cell is by itself.
In silico stu stud as a Source of Evidence for Hazard Identification
computer modelling
* How a variant can mutate
* How substances will be stored, excreted etc. in & from body
Note Garbage in, garbage out – data should be quality to get quality conclusions
* Eg. MMDA claimed to have models that helped in their decision making, & their outputs were always crap – maam questions the data of MMDA
* Still needs data from other fields
What is assessed during Hazard Identification?
5
- Contaminants, its degradation products, and metabolites
- Determinants of toxicity
- Adverse health effects – typically broad
- Characterization based on effects, target organs, and mode of action
- Weight of evidence analysis
wadcc
List
Determinants of hazards’ toxicity
6
- Level, frequency, and duration of dose/exposure
- Demographic of exposed populations
- Routes of exposure
- Absorption and metabolism of contaminants
- Physical form of contaminant
- Presence of other contaminants (synergistic or additive effects)
Describe
Adverse health effects
- usually broad
Includes
1. Overt diseases (cancer, birth defects)
1. More subtle biological effects (alterations in gene expression)
1. Upstream effects - effects that can play an early role leading to disease
Define
Upstream effect
effects that can play an early role in leading to disease
Biological endpoint
- A direct marker of disease progression;
- Describes health effects (or probability of health effects) from exposure to a hazard
Define
mode of action
how substance affects the target cell or organs
Define
Weight of evidence analysis
judgment on whether the body of evidence available supports the conclusion that a substance is a hazard to humans
- Assess which ones to follow/not follow
- Look at methodology & method of analysis
- Ex. cigarettes: tobacco is organic, formaldehyde is preservative, tar is carcinogen, nicotine is stimulant
Importance of Hazard Identification
- High quality scientific studies = best evidence
- Human data is the gold standard
- Use of Epidemiological studies
- Use of Toxicological studies
Issue w/ High quality scientific studies
best evidence, BUT
1. Not always available
2. Design and methodological limitations
Issue w/ Human data
1. Use of Epidemiological studies
1. Use of Toxicological studies
Studies examine occupational populations not representative of general population
aka, Done on healthier humans
Issue w/ Use of Epidemiological studies
- Limited by uncertainties on amount and duration of exposure;
- Presence of potential confounders
Issue w/ Use of Toxicological studies
Challenge of determining relevance to humans
List
Dose-Response Assessment Goals
2
- Characterize relationship between dose & adverse effect
- To estimate toxicity values, the dose makes the poison
*
Define adverse effects
likelihood/severity